Variceal Bleeding a Predictor of Mortality in Patient Admitted with Liver Cirrhosis

Authors

  • Syed Nadir Shah Department of Medicine, Sandman Provincial Hospital Quetta, Pakistan.
  • Moneeb Ur Rehman Department of Medicine, Sandman Provincial Hospital Quetta, Pakistan.
  • Hasil Khan Department of Medicine, Sandman Provincial Hospital Quetta, Pakistan.
  • Javeria Mansoor Department of Medicine, Sandman Provincial Hospital Quetta, Pakistan.
  • Fazal ur Rehman Department of Medicine, Sandman Provincial Hospital Quetta, Pakistan.
  • Rida Manzoor Department of Medicine, Sandman Provincial Hospital Quetta, Pakistan.
  • Sana Ullah Kakar Department of Medicine, Sandman Provincial Hospital Quetta, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v2i02.112

Keywords:

Variceal bleeding, liver cirrhosis, Meld score, Portal Hypertension, Child PUGH, Chronic liver disease, Mortality

Abstract

This study aims to assess the risk of mortality in cirrhotic patients with acute variceal bleeding at a tertiary care hospital. Variceal bleeding is a common and life-threatening complication in liver cirrhosis, significantly contributing to early mortality. The study utilized a cohort design with 128 patients, divided into two groups: those with acute variceal bleeding (exposed) and those without (unexposed). Baseline clinical data, including Child-Pugh and MELD scores, were collected. The primary outcome was 30-day mortality. Key findings include a mean age of 55.7 ± 22.1 years, with 52.8% males and 56.3% from rural areas. The average Child-Pugh score was 10.1 ± 3.2, and the mean MELD score was 24.1 ± 10.1. The frequency of hematemesis and melena as presenting complaints was evenly split at 50%. Mortality was observed in 49.2% of the patients with variceal bleeding. Statistical analysis using chi-square tests revealed a significant association between variceal bleeding and increased mortality (p < 0.05). Confounding factors such as age, gender, and comorbid conditions were controlled through stratification, with relative risk calculations confirming the elevated mortality risk. This study highlights the critical need for timely interventions in cirrhotic patients with variceal bleeding and underscores the importance of comprehensive management strategies to reduce mortality in this high-risk population.

References

Bajaj, J. S. (2019). Altered gut microbiota in patients with cirrhosis and its relationship to the development of infections. Clinical Liver Disease, 13(5), 154-157. https://10.1002/cld.827

Bernard, B., Grangé, J.-D., Khac, E. N., Amiot, X., Opolon, P., & Poynard, T. (1999). Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis. Hepatology, 29(6), 1655–1661. https://doi.org/10.1002/hep.510290608

Bosch, J., Abraldes, J. G., Berzigotti, A., & García-Pagan, J. C. (2009). The clinical use of HVPG measurements in chronic liver disease. Nature Reviews Gastroenterology & Hepatology, 6(10), 573–582. https://doi.org/10.1038/nrgastro.2009.149

Brocchi, E., Caletti, G., Brambilla, G., La Mantia, L., Lupinacci, G., & Pisano, G…. (1988). Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The New England journal of medicine, 319(15), 983–989. https://doi.org/10.1056/NEJM198810133191505

Burroughs, A. K., & Triantos, C. (2008). Predicting failure to control bleeding and mortality in acute variceal bleeding. Journal of Hepatology, 48(2), 185–188. https://doi.org/10.1016/j.jhep.2007.11.006

Carbonell, N., Pauwels, A., Serfaty, L., Fourdan, O., Lévy, V. G., & Poupon, R. (2004). Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology, 40(3), 652–659. https://doi.org/10.1002/hep.20339

D’Amico, G., Garcia-Pagan, J. C., Luca, A., & Bosch, J. (2006). Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic Review. Gastroenterology, 131(5), 1611–1624. https://doi.org/10.1053/j.gastro.2006.09.013

D'Amico, G. (2003). Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology, 38(3), 599–612. https://doi.org/10.1053/jhep.2003.50385

de Franchis, R., & Primignani, M. (2001). NATURAL HISTORY OF PORTAL HYPERTENSION IN PATIENTS WITH CIRRHOSIS. Clinics in Liver Disease, 5(3), 645–663. https://doi.org/10.1016/s1089-3261(05)70186-0

Feu J. C. Garcia-Pagan, Bosch, J., Luca, A., Angels Escorsell, Rodés, J., & Josep Terés. (1995). Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. The Lancet, 346(8982), 1056–1059. https://doi.org/10.1016/s0140-6736(95)91740-3

Garcia- Pagán, J.-C., Gracia-Sancho, J., & Bosch, J. (2012). Functional aspects on the pathophysiology of portal hypertension in cirrhosis. Journal of Hepatology, 57(2), 458–461. https://doi.org/10.1016/j.jhep.2012.03.007

Garcia-Pagan, J. C., Caca, K., Bureau, C., Laleman, W., Appenrodt, B., Luca, A., Abraldes, J. G., Nevens, F., Vinel, J. P., Mössner, J., & Bosch, J. (2010). Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding. New England Journal of Medicine, 362(25), 2370–2379. https://doi.org/10.1056/nejmoa0910102

Garcia-Tsao, G., Groszmann, R. J., Fisher, R. L., Conn, H. O., Atterbury, C. E., & Glickman, M. (1985). Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology, 5(3), 419–424. https://doi.org/10.1002/hep.1840050313

Garcia-Tsao, G., Sanyal, A. J., Grace, N. D., & Carey, W. (2007). Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology, 46(3), 922–938. https://doi.org/10.1002/hep.21907

Garcia–Tsao, G. (2001). Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology, 120(3), 726–748. https://doi.org/10.1053/gast.2001.22580

Ge, P. S., Runyon, B. A., & Kamath, P. S. (2019). Modern medical management of cirrhosis. Current Opinion in Gastroenterology, 35(3), 197-202.

Ginès, P., Solà, E., Angeli, P., Wong, F., Nadim, M. K., & Kamath, P. S. (2018). Hepatorenal syndrome. Nature Reviews Disease Primers, 4(1), 1–17. https://doi.org/10.1038/s41572-018-0022-7

Graham, D. Y., & Smith, J. L. (1981). The course of patients after variceal hemorrhage. Gastroenterology, 80(4), 800–809. https://pubmed.ncbi.nlm.nih.gov/6970703/

Groszmann, R. J., Bosch, J., Grace, N. D., Conn, H. O., Garcia-Tsao, G., Navasa, M., Alberts, J., Rodes, J., Fischer, R., Bermann, M., Rofe, S., Patrick, M., & Lerner, E. (1990). Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology, 99(5), 1401–1407. https://doi.org/10.1016/0016-5085(90)91168-6

Groszmann, R. J., Garcia-Tsao, G., Bosch, J., Grace, N. D., Burroughs, A. K., Planas, R., Escorsell, A., Garcia-Pagan, J. C., Patch, D., Matloff, D. S., Gao, H., & Makuch, R. (2005). Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis. New England Journal of Medicine, 353(21), 2254–2261. https://doi.org/10.1056/nejmoa044456

Groszmann, R. J., Garcia-Tsao, G., Bosch, J., Grace, N. D., Burroughs, A. K., Planas, R., Escorsell, A., Garcia-Pagan, J. C., Patch, D., Matloff, D. S., Gao, H., & Makuch, R. (2005). Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis. New England Journal of Medicine, 353(21), 2254–2261. https://doi.org/10.1056/nejmoa044456

Lefkowitch, J. H. (2005). Morphology of Alcoholic Liver Disease. Clinics in Liver Disease, 9(1), 37–53. https://doi.org/10.1016/j.cld.2004.11.001

McCormick, P. A. (2001). Improving prognosis following a first variceal haemorrhage over four decades. Gut, 49(5), 682–685. https://doi.org/10.1136/gut.49.5.682

Reverter, E., Tandon, P., Augustin, S., Turon, F., Casu, S., Bastiampillai, R., Keough, A., Llop, E., González, A., Seijo, S., Berzigotti, A., Ma, M., Genescà, J., Bosch, J., García–Pagán, J. C., & Abraldes, J. G. (2014). A MELD-Based Model to Determine Risk of Mortality Among Patients With Acute Variceal Bleeding. Gastroenterology, 146(2), 412-419.e3. https://doi.org/10.1053/j.gastro.2013.10.018

Ripoll, C., Groszmann, R., Garcia–Tsao, G., Grace, N., Burroughs, A., Planas, R., Escorsell, A., Garcia–Pagan, J. C., Makuch, R., Patch, D., Matloff, D. S., & Bosch, J. (2007). Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis. Gastroenterology, 133(2), 481–488. https://doi.org/10.1053/j.gastro.2007.05.024

Ripoll, C., Groszmann, R. J., Garcia-Tsao, G., Bosch, J., Grace, N., Burroughs, A., Planas, R., Escorsell, A., Garcia-Pagan, J. C., Makuch, R., Patch, D., & Matloff, D. S. (2009). Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. Journal of Hepatology, 50(5), 923–928. https://doi.org/10.1016/j.jhep.2009.01.014

Downloads

Published

2024-10-28

How to Cite

Shah, S. N., Moneeb Ur Rehman, Khan, H., Mansoor, J., Fazal ur Rehman, Manzoor, R., & Kakar, S. U. (2024). Variceal Bleeding a Predictor of Mortality in Patient Admitted with Liver Cirrhosis. Indus Journal of Bioscience Research, 2(02), 111–118. https://doi.org/10.70749/ijbr.v2i02.112

Issue

Vol. 2 No. 02 (2024): Indus Journal of Bioscience Research

Section

Original Article

License

Copyright (c) 2024 Indus Journal of Bioscience Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)

1 2 3 > >>